Trpv1 compounds in a biodegradable polymer carrier
AssigneeWarsaw Orthopedic, Inc.
InventorsNicholas A. Moore, Danielle L. Clay
Life of this patent
Estimating the term…
Loading patent…
AssigneeWarsaw Orthopedic, Inc.
InventorsNicholas A. Moore, Danielle L. Clay
Estimating the term…
Effective treatments of pain for extended periods of time are provided. Through the administration of an effective amount of a TRPV1 compound (e.g., capsaicinoid compound) at or near a target site, one can relieve pain caused by diverse sources, including but not limited to, postoperative pain, spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discogenic back pain and joint pain, as well as pain that is incidental to surgery. When appropriate formulations are provided within biodegradable polymers, this relief can be continued for at least three days. In some embodiments, the relief can be for at least twenty-five days, at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days.
-12. (canceled)
A method for treating acute pain, wherein the method comprises implanting a drug depot in an organism to reduce or treat pain, wherein said drug depot comprises a capsaicinoid compound in an amount from about 0.1 wt. % to about 30 wt. % of the drug depot and at least one biodegradable polymer.
Dependencies are inferred from the claim text.